Zealand, Boehringer’s drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to 14.9% weight loss after 46 …
